A data leak revealed records connecting 4,580 swap orders to public blockchain deposits, Monero destinations, and client IP addresses. This leak allows tracing transaction activity across networks by linking a public-chain deposit, the Monero exchange destination, and the client's IP address. The combined data creates a significant privacy risk by exposing the full transaction path, which would otherwise remain partially hidden if viewed separately. This breach highlights vulnerabilities in privacy for users conducting swaps involving Monero and public blockchains.
The leak linking 4,580 swaps to Monero and client IPs provides context for readers following cryptocurrency privacy issues. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 29, 2026 14:02 WIB: out of 50 priced major cryptocurrencies, 7 rose and 42 fell. Notable movers include THETA at Rp3.150 with a 1-day change of -3.73% and 100% sell order activity, ADA at Rp3.611 with a -3.68% change and 72% sell activity, and ALGO at Rp1.820 with a -3.45% change and 96% sell activity.
DNO ASA, a Norwegian oil and gas company, announced a cash dividend of NOK 0.375 per share to be paid around November 17, 2026. Shareholders registered by November 9, 2026, will receive the dividend, with shares trading ex-dividend starting November ...
TGS ASA announced that its shares will be traded ex-dividend at NOK 1.45 per share starting October 29, 2026. This means investors buying the stock from this date will not receive the upcoming dividend payment. The dividend distribution follows appro...
Metaplex (MPLX) surged 36.62% on October 29, significantly outperforming the broader NFT sector, which rose 2.56%. This sharp rally followed a period of low trading activity but lacked a clear catalyst such as a project update or announcement. Metapl...
TME Pharma has entered a binding exclusive negotiation agreement with Japanese biotech TMS Co., Ltd. to develop and commercialize NOX-A12 for glioblastoma. TME Pharma receives €150,000 for exclusivity and expects around €10 million upfront plus over ...
TME Pharma has entered a binding exclusive negotiation agreement with Japanese biotech company TMS Co., Ltd. for the global rights to NOX-A12, a drug targeting glioblastoma brain cancer. TMS will create a subsidiary to fund and advance clinical devel...
